Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
– Sell
-30,000
Closed -$111K – 396
2020
Q1
$111K Buy
+30,000
New +$4.96M ﹤0.01% 313
2014
Q1
– Sell
-400,000
Closed -$355K – 452
2013
Q4
$355K Buy
+400,000
New +$36M 0.01% 336
2013
Q3
– Sell
-300,000
Closed -$545K – 444
2013
Q2
$545K Buy
+300,000
New +$25.8M 0.01% 406

Other funds holding CLX

UBS O'Connor's CLX Position: Q1 2016 in Review

UBS O'Connor sold out of Clorox (CLX) in Q1 2016, closing a stake of 36,150 shares — an estimated $4.58M sold.

UBS O'Connor first reported a position in CLX in Q4 2014 and held it in 4 quarters. The position peaked at $16.2M in Q1 2015. 853 funds tracked by Wall St. Rank hold CLX as of Q1 2016.

  • UBS O'Connor reported no remaining Clorox position as of Q1 2016 after selling out during the quarter.
  • UBS O'Connor sold 36,150 Clorox shares in Q1 2016, an estimated $4.58M.
  • UBS O'Connor first reported a position in Clorox in Q4 2014 and held it in 4 quarters.
  • UBS O'Connor's Clorox position peaked at $16.2M in Q1 2015.
  • 853 funds tracked by Wall St. Rank held Clorox as of Q1 2016.

Based on UBS O'Connor's 13F filing for Q1 2016, filed 13 May 2016.